Cargando…

Cerebrospinal fluid microglia and neurodegenerative markers in twins concordant and discordant for psychotic disorders

Schizophrenia and bipolar disorder are debilitating psychiatric disorders with partially shared symptomatology including psychotic symptoms and cognitive impairment. Aberrant levels of microglia and neurodegenerative cerebrospinal fluid (CSF) markers have previously been found in schizophrenia and b...

Descripción completa

Detalles Bibliográficos
Autores principales: Johansson, Viktoria, Jakobsson, Joel, Fortgang, Rebecca G., Zetterberg, Henrik, Blennow, Kaj, Cannon, Tyrone D., Hultman, Christina M., Wetterberg, Lennart, Landén, Mikael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5509775/
https://www.ncbi.nlm.nih.gov/pubmed/28039552
http://dx.doi.org/10.1007/s00406-016-0759-5
_version_ 1783250071685431296
author Johansson, Viktoria
Jakobsson, Joel
Fortgang, Rebecca G.
Zetterberg, Henrik
Blennow, Kaj
Cannon, Tyrone D.
Hultman, Christina M.
Wetterberg, Lennart
Landén, Mikael
author_facet Johansson, Viktoria
Jakobsson, Joel
Fortgang, Rebecca G.
Zetterberg, Henrik
Blennow, Kaj
Cannon, Tyrone D.
Hultman, Christina M.
Wetterberg, Lennart
Landén, Mikael
author_sort Johansson, Viktoria
collection PubMed
description Schizophrenia and bipolar disorder are debilitating psychiatric disorders with partially shared symptomatology including psychotic symptoms and cognitive impairment. Aberrant levels of microglia and neurodegenerative cerebrospinal fluid (CSF) markers have previously been found in schizophrenia and bipolar disorder. We aimed to analyze familial and environmental influences on these CSF markers and their relation to psychiatric symptoms and cognitive ability. CSF was collected from 17 complete twin pairs, nine monozygotic and eight dizygotic, and from one twin sibling. Two pairs were concordant for schizophrenia, and 11 pairs discordant for schizophrenia, schizoaffective disorder or bipolar disorder, and four pairs were not affected by psychotic disorders. Markers of microglia activation [monocyte chemoattractant protein-1 (MCP-1), chitinase 3-like protein 1 (YKL-40), and soluble cluster of differentiation 14 (sCD14)], markers of β-amyloid metabolism (AβX-38, AβX-40, AβX-42 and Aβ1-42), soluble amyloid precursor proteins (sAPP-α and sAPP-β), total tau (T-tau), phosphorylated tau (P-tau), and CSF/serum albumin ratio were measured in CSF using immunoassays. Heritability of the CSF markers was estimated, and associations to psychiatric and cognitive measurements were analyzed. Heritability estimates of the microglia markers were moderate, whereas several neurodegenerative markers showed high heritability. In contrast, AβX-42, Aβ1-42, P-tau and CSF/serum albumin ratio were influenced by dominant genetic variation. Higher sCD14 levels were found in twins with schizophrenia or bipolar disorder compared to their not affected co-twins, and higher sCD14-levels were associated with psychotic symptoms. The study provides support for a significant role of sCD14 in psychotic disorders and a possible role of microglia activation in psychosis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00406-016-0759-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5509775
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-55097752017-07-28 Cerebrospinal fluid microglia and neurodegenerative markers in twins concordant and discordant for psychotic disorders Johansson, Viktoria Jakobsson, Joel Fortgang, Rebecca G. Zetterberg, Henrik Blennow, Kaj Cannon, Tyrone D. Hultman, Christina M. Wetterberg, Lennart Landén, Mikael Eur Arch Psychiatry Clin Neurosci Original Paper Schizophrenia and bipolar disorder are debilitating psychiatric disorders with partially shared symptomatology including psychotic symptoms and cognitive impairment. Aberrant levels of microglia and neurodegenerative cerebrospinal fluid (CSF) markers have previously been found in schizophrenia and bipolar disorder. We aimed to analyze familial and environmental influences on these CSF markers and their relation to psychiatric symptoms and cognitive ability. CSF was collected from 17 complete twin pairs, nine monozygotic and eight dizygotic, and from one twin sibling. Two pairs were concordant for schizophrenia, and 11 pairs discordant for schizophrenia, schizoaffective disorder or bipolar disorder, and four pairs were not affected by psychotic disorders. Markers of microglia activation [monocyte chemoattractant protein-1 (MCP-1), chitinase 3-like protein 1 (YKL-40), and soluble cluster of differentiation 14 (sCD14)], markers of β-amyloid metabolism (AβX-38, AβX-40, AβX-42 and Aβ1-42), soluble amyloid precursor proteins (sAPP-α and sAPP-β), total tau (T-tau), phosphorylated tau (P-tau), and CSF/serum albumin ratio were measured in CSF using immunoassays. Heritability of the CSF markers was estimated, and associations to psychiatric and cognitive measurements were analyzed. Heritability estimates of the microglia markers were moderate, whereas several neurodegenerative markers showed high heritability. In contrast, AβX-42, Aβ1-42, P-tau and CSF/serum albumin ratio were influenced by dominant genetic variation. Higher sCD14 levels were found in twins with schizophrenia or bipolar disorder compared to their not affected co-twins, and higher sCD14-levels were associated with psychotic symptoms. The study provides support for a significant role of sCD14 in psychotic disorders and a possible role of microglia activation in psychosis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00406-016-0759-5) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2016-12-30 2017 /pmc/articles/PMC5509775/ /pubmed/28039552 http://dx.doi.org/10.1007/s00406-016-0759-5 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Paper
Johansson, Viktoria
Jakobsson, Joel
Fortgang, Rebecca G.
Zetterberg, Henrik
Blennow, Kaj
Cannon, Tyrone D.
Hultman, Christina M.
Wetterberg, Lennart
Landén, Mikael
Cerebrospinal fluid microglia and neurodegenerative markers in twins concordant and discordant for psychotic disorders
title Cerebrospinal fluid microglia and neurodegenerative markers in twins concordant and discordant for psychotic disorders
title_full Cerebrospinal fluid microglia and neurodegenerative markers in twins concordant and discordant for psychotic disorders
title_fullStr Cerebrospinal fluid microglia and neurodegenerative markers in twins concordant and discordant for psychotic disorders
title_full_unstemmed Cerebrospinal fluid microglia and neurodegenerative markers in twins concordant and discordant for psychotic disorders
title_short Cerebrospinal fluid microglia and neurodegenerative markers in twins concordant and discordant for psychotic disorders
title_sort cerebrospinal fluid microglia and neurodegenerative markers in twins concordant and discordant for psychotic disorders
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5509775/
https://www.ncbi.nlm.nih.gov/pubmed/28039552
http://dx.doi.org/10.1007/s00406-016-0759-5
work_keys_str_mv AT johanssonviktoria cerebrospinalfluidmicrogliaandneurodegenerativemarkersintwinsconcordantanddiscordantforpsychoticdisorders
AT jakobssonjoel cerebrospinalfluidmicrogliaandneurodegenerativemarkersintwinsconcordantanddiscordantforpsychoticdisorders
AT fortgangrebeccag cerebrospinalfluidmicrogliaandneurodegenerativemarkersintwinsconcordantanddiscordantforpsychoticdisorders
AT zetterberghenrik cerebrospinalfluidmicrogliaandneurodegenerativemarkersintwinsconcordantanddiscordantforpsychoticdisorders
AT blennowkaj cerebrospinalfluidmicrogliaandneurodegenerativemarkersintwinsconcordantanddiscordantforpsychoticdisorders
AT cannontyroned cerebrospinalfluidmicrogliaandneurodegenerativemarkersintwinsconcordantanddiscordantforpsychoticdisorders
AT hultmanchristinam cerebrospinalfluidmicrogliaandneurodegenerativemarkersintwinsconcordantanddiscordantforpsychoticdisorders
AT wetterberglennart cerebrospinalfluidmicrogliaandneurodegenerativemarkersintwinsconcordantanddiscordantforpsychoticdisorders
AT landenmikael cerebrospinalfluidmicrogliaandneurodegenerativemarkersintwinsconcordantanddiscordantforpsychoticdisorders